Questions about “Symptoms of Heart Problems in Children”? Surgeon Dr. Kamal Pourmoghadam explains in a new article

Dr Kamal Pourmoghadam, surgeon in Orlando Florida

Dr Kamal Pourmoghadam, surgeon in Orlando Florida

Dr Kamal K Pourmoghadam, Florida

Dr Kamal K Pourmoghadam, Florida

Dr Kamal Pourmoghadam, surgeon in Orlando Florida

Dr Kamal Pourmoghadam, surgeon in Orlando Florida

Dr Kamal Pourmoghadam, surgeon in Orlando Florida

Dr Kamal Pourmoghadam, surgeon in Orlando Florida

Website of Dr Kamal Pourmoghadam, Orlando, Florida

Website of Dr Kamal Pourmoghadam, Orlando, Florida

In his newest article, pediatric heart surgeon Dr. Kamal K. Pourmoghadam explains children’s heart issues and their symptoms in layman’s terms.

Dr. Kamal K. Pourmoghadam (N/A:N/A)

If you observe any of these symptoms of a heart problem, take your child to your primary care physician. They will refer you to a pediatric cardiologist – children’s heart specialist for further tests”

— Dr. Kamal Pourmoghadam, Orlando, Florida

ORLANDO, FLORIDA, UNITED STATES, May 31, 2019 /EINPresswire.com/ — Did you know that one in every 100 children suffer from a heart problem? This includes heart defects that may be present from birth, or developed at birth, or turned into a defect as the child grew up. These defects are usually treated with the help of medicine, surgery, or several medical procedures combined.

To explain, medical doctor and surgeon Kamal Pourmoghadam, MD has published an informational article on this subject in an easy-to-understand way. The complete article will be published on the Blog of Dr. Pourmoghadam at https://drpourmoghadam.home.blog/

At times, it is difficult to identify a heart defect, and many children continue to live a normal life with little to no problems. However, in some cases, children may find difficulty in performing normal tasks such as running or walking due to a heart problem. This happens when the heart problem goes undetected at an earlier stage and becomes a huge health concern later on in life.

Hence, heart defects must be treated as soon as possible and to detect them in the first place, the following are some symptoms that you must watch out for.

Common Signs and Symptoms of Heart Problems in Children

Heart problems can occur in infants, toddlers, and older children, and these children may exhibit the following symptoms concerning heart defects:
1. Infants
* Feeling out of breath when feeding milk
* Becoming sweaty during feeds
* Gums or tongue turning blue
* Passing out

2. Toddlers
* Failing to stay as active as other children
* Feeling fatigued and getting out of breath during simple activities as compared to other kids of that age
* Getting sweaty quicker than other kids. Sometimes after even less activity than other children.
* Blue skin color (gums/tongue)
* Frequent fainting
3. Teens
* Chest pain while performing exercises
* Fatigue and dizziness
* Passing out
* Swelling in the legs, abdomen, and skin around the eyes
* Shortness of breath during exercise or while playing sports
* Getting tired easily

When to See a Doctor

If you observe any of these symptoms of a heart problem, take your child to your primary care physician. They will refer you to a pediatric cardiologist – children’s heart specialist. The children’s heart specialist will perform the necessary tests to diagnose the type of heart defect your child is suffering from.

Some of the tests that a pediatric cardiologist will conduct are:

* Chest X-ray which is a simple X-ray to identify any hole or lump in the chest.
* An ECG is another test in which wires are attached using sticky dots on the chest, arms, and legs. These wires diagnose the electrical activity of the heart. This test takes only a few minutes and doesn’t cause any sort of pain. However, your child will be required to stay composed during the test.
* An ultrasound scan, known as an echocardiogram, will also be conducted. In this type of test, a handheld scanner scans the chest and stomach and presents your child’s heart’s image on a TV monitor. In this test, your child may feel pressure as the scanner is pressed firmly against the skin. So, it can be uncomfortable. However, it is not painful.
Some common treatments for heart defects are medicines, surgery, and procedures like using a catheter to stop blood from flowing in between the chambers, etc.

About Dr. Kamal K. Pourmoghadam

Dr. Kamal Pourmoghadam is a pediatric cardiac surgeon at The Heart Center at Arnold Palmer Hospital for Children. He is board certified in general surgery, cardiothoracic surgery and congenital cardiac surgery.

Dr. Pourmoghadam earned his bachelor’s degree from University of California, Berkeley, and his medical degree from Albany Medical College in New York. He trained for adult cardiac surgery at the University of Miami, Jackson Memorial Hospital in Miami, and for congenital cardiac surgery at the University of Washington, Seattle Children’s Hospital in Seattle.

Dr. Pourmoghadam is a professor of surgery at the University of Central Florida College of Medicine, practicing congenital cardiac surgery for over twenty years and has been active in clinical research. He has extensive experience in neonatal and infant cardiac surgery and has special interest in the repair of single ventricle physiology patients and research in univentricular hearts.

References:

Website: https://kamalpourmoghadam.com
Blog: https://drpourmoghadam.home.blog/
News: https://hippocratesguild.com/dr-kamal-pourmoghadam
News: https://medicogazette.com/dr-kamal-pourmoghadam#425f92ce-0ccc-4fe2-8c31-56cf497704f4
News: https://hype.news/dr-kamal-pourmoghadam/
News report about Dr. Pourmoghadam: http://www.tiogapublishing.com/features/the_marketplace/covington-tot-returns-home-to-pennsylvania-after-lengthy-oklahoma-hospital/article_04865c00-0ae5-11e1-aec8-001cc4c002e0.html
Linkedin: https://www.linkedin.com/in/kamal-pourmoghadam-9a796157/

Dr. Kamal K. Pourmoghadam
Arnold Palmer Hospital for Children
+ + + + + +1 407-255-2164
email us here
Visit us on social media:
LinkedIn

Testing Newborns for Heart Defects – Lee Health


Source: EIN Presswire

2019 Global Nursing Care Market Size, Share, Trends and Competitor Analysis

The Business Research Company adds "Nursing Care Market By Service Type, By End-User, By Type Of Expenditure, Key Company Profiles and Global 2022 Forecasts

The Top Opportunities In The Global Nursing Care Market Will Arise In The Nursing Care Facilities Segment Which Will Gain $126.1 Billion Of Global Annual Sales By 2022.”

— Abdul Wasay

LONDON, GREATER LONDON, UK, May 31, 2019 /EINPresswire.com/ — The global market for nursing care is expected to reach a value of nearly above $1 trillion by 2022, having grown at an annual rate of above 8% since 2018.

Growth in the nursing care market in the historic period resulted from the rapid growth in the size of the elderly population, strong economic growth in emerging markets, changes in social patterns, and health insurance reforms. Factors that negatively affected growth in the historic period were low healthcare access in some countries, shortages of skilled human resources, lack of insurance coverage and weak wage growth in developed economies. Going forward, faster economic growth, technological developments and increasingly busy and sedentary lifestyles will drive growth. Factors that could hinder the growth of this market in the future include shortages of skilled human resources, insufficient public health insurance coverage, and a rising number of home health entities falling into insolvency.

Request For A Free Sample For The Global Nursing Care Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2333&type=smp

The top opportunities in the global nursing care market will arise in the nursing care facilities segment, which will gain more than $126 billion of global annual sales by 2022. The nursing care market size will gain the most in the USA at $55.23 billion. Nursing care market-trend-based strategies include the launch of integrated care services, implementation of remote patient monitoring and health management programs, and the launch of custom-care packages. Player-adopted strategies in the nursing care industry include expansion through mergers and acquisitions and construction of new medical centers.

To take advantage of the opportunities, The Business Research Company recommends the nursing care companies to consider increasing remote controlled self-diagnosis services, expanding in emerging markets, focusing on expanding through collaborations, implementing competitive pricing, leveraging social media to maximize reach, increasing visibility through a high-performance website, and offering services for aged women.

Read More On The Report For The Global Nursing Care Market At:
https://www.thebusinessresearchcompany.com/report/nursing-care-market

The global nursing care market is highly fragmented. The top ten competitors in the global nursing care market made up 3.1% of the total market in 2018. Players in the market include Genesis Healthcare, Kaiser Permanente, Brookdale Senior Living, Kindred Healthcare, LLC and The Ensign Group, Inc.

Nursing Care Market By Service Type (Nursing Care Facilities, Home Health Care Providers, Retirement Communities, Group Care Homes); By End-User Gender (Female, Male); By Type Of Expenditure (Public, Private) – Global Forecast To 2022 is one of a series of new reports from The Business Research Company that provides nursing care market overviews, analyzes and forecasts nursing care market size and growth for the global nursing care market, nursing care market share, nursing care market players, nursing care market size, nursing care market segments and geographies, nursing care market trends, nursing care market drivers and nursing care market restraints, nursing care market’s leading competitors’ revenues, profiles and market shares. The nursing care market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More
Read Nursing Care Market By Service Type (Nursing Care Facilities, Home Health Care Providers, Retirement Communities, Group Care Homes); By End-User Gender (Female, Male); By Type Of Expenditure (Public, Private) – Global Forecast To 2022 from The Business Research Company for information on the following:

Markets Covered: global nursing care market and segments, home healthcare providers, nursing care facilities, group care homes and retirement communities

Data Segmentations: nursing care market size, global and by country; historic and forecast size, and growth rates for the world, 7 regions and 12 countries

Nursing Care Market Organizations Covered: Genesis Healthcare, Kaiser Permanente, Brookdale Senior Living, Kindred Healthcare, LLC and The Ensign Group, Inc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Time Series: Five years historic (2014-18) and forecast (2018-22).

Other Information And Analyses: PESTEL analysis, nursing care market customer information, nursing care market product/service analysis – product examples, nursing care market trends and opportunities, drivers and restraints, key mergers and acquisitions, global nursing care market in 2019 – countries offering most new opportunities
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The Nursing Care Industry: The report explains a number of strategies for companies in the nursing care market, based on industry trends and company analysis.

Opportunities For Companies In The Nursing Care Sector: The report reveals where the global nursing care industry will put on most $ sales up to 2022.

Interested to know more about The Business Research Company?
The Business Research Company has published over 300 industry reports, covering over 2400 market segments and 56 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. Here is a list of reports from The Business Research Company similar to Nursing Care Market By Service Type (Nursing Care Facilities, Home Health Care Providers, Retirement Communities, Group Care Homes); By End-User Gender (Female, Male); By Type Of Expenditure (Public, Private) – Global Forecast To 2022:

Hospitals And Clinics Market By Service Type (Hospitals, Clinics); By End User-Gender (Female, Male); By Expenditure (Public, Private) – Global Forecast To 2022

Dental Services Market By Type (General Dentistry, Orthodontics And Prosthodontics And Oral Surgery), By End Use Industry, By Country, By Competitor And Regional Analysis – Global Forecast To 2022

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Himachal Mukhopadhyay Shares Insight into the Growing Number of FDA-Approved Biosimilars

Himachal Mukhopadhyay

ROSEVILLE, CALIFORNIA, USA, May 31, 2019 /EINPresswire.com/ — Healthcare professional Himachal Mukhopadhyay has studied developing trends of biosimilars for decades. He helps shed light on FDA-approved biosimilar medications and their implications for patients now and in the future.

Himachal Mukhopadhyay has over 20 years in the healthcare industry, where he’s taken on roles in Operations, Delivery, Engineering, and Sales/Business Development. As a leader and strategic advisor, he studies ongoing healthcare trends to provide in-depth research and creative solutions to his clients. Below, he remarks on the recent advancements in biological medicine and the increase of FDA-approved biosimilars, which have major implications for healthcare patients around the world.

“Last year, the number of FDA-approved biosimilars nearly doubled thanks to advancements in technology and research,” says Himachal Mukhopadhyay. “Because of these approvals, patients everywhere can have access to specialized biological treatments at a much lower cost.”

Biological Medicine vs. Conventional Medication

Biological products are advanced scientific discoveries that encompass products like vaccines, gene therapy, blood components, and recombinant therapeutic proteins. Biologics are composed of a range of substances and often include living entities like tissues and cells to deliver effective treatment results where no other treatments may be available.

Conventional medication is largely made up of chemically-synthesized ingredients whose structures are well known after years of study and development. Biological medicine, on the other hand, is made up of complex biological mixtures that implement cutting-edge biomedical research to treat illnesses and conditions. In addition, these medications are more susceptible to damage from heat and microbial contamination. This tends to drive up the cost for healthcare patients as do the patented ingredients, processes, and price of past research.

Biosimilars Offer Nearly-Identical Alternatives

Himachal Mukhopadhyay notes that because biologics are so complex and specialized, they tend to be highly expensive and not a valid option for many patients whose illnesses or conditions could otherwise benefit from them. Biosimilars are copycat formulas of approved biologic medicine. The effectiveness of a biosimilar medication is tested against the effectiveness of the reference product in extensive laboratory and clinical research to determine if it’s a viable option for healthcare patients.

Before a biosimilar can be released for public use, it first must prove that it produces no meaningful differences from the product it imitates in terms of effectiveness and safety. Recently, the FDA has approved more biosimilars than ever, creating generic alternatives for patients around the world.

Biosimilars Mean Cheaper Treatment Options for Many

The biggest benefit of biosimilars for patients is the difference in cost. Patented formulas allow manufacturers to control pricing as they see fit, but biosimilars give competitors and secondary manufacturers the opportunity to provide similar medication at a fraction of the cost (similar to brand name medications and their generic counterparts).

“As the FDA approves more and more biosimilars, healthcare patients can expect to encounter more specialized treatment and care at much more affordable pricing,” says Himachal Mukhopadhyay. “In the future, this will mean greater access to complex medicine for international patients and ultimately a much healthier populace as a result.”

Caroline Hunter
Web Presence, LLC
+1 786-551-9491
email us here


Source: EIN Presswire

HIV Therapeutics Market 2019 Global Trend, Segmentation and Opportunities, Forecast 2025

WiseGuyReports.com adds “Global HIV Therapeutics Market Size, Status and Forecast 2019-2025” reports to its database.

PUNE, MAHARASHTRA, INDIA, May 31, 2019 /EINPresswire.com/ — HIV Therapeutics Market:

Executive Summary

The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.
HIV spreads through fluidic exchange with some infected person such as blood transfer or sharing needles with someone who is HIV infected. In addition, HIV can spread from infected mother to child during pregnancy. Some of the symptoms of HIV infection are slight fever, fatigue, swollen glands, headaches and muscle aches.
HIV infection has no cure but there are treatments which help to stabilize or reduce this infection so that it does not lead to AIDS. HIV therapeutics market is growing at a significant rate due to increase in the HIV infected cases and growing awareness about the same. HIV infection can be treated by various therapeutics such as nucleoside/ nucleotide reverse transcriptase inhibitor, integrase inhibitor, HIV-1 protease inhibitor, non-nucleoside reverse transcriptase inhibitor, pharmacokinetic enhancer and entry inhibitor.

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/4080551-global-hiv-therapeutics-market-size-status-and-forecast-2019-2025

This report focuses on the global HIV Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HIV Therapeutics development in United States, Europe and China.

The key players covered in this study
Boehringer Ingelheim International GmbH
Merck & Co.
ViiV Healthcare
AbbVie
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb
Gilead Sciences
Johnson & Johnson
Cipla Limited

Market segment by Type, the product can be split into
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Entry and Fusion Inhibitors
Protease Inhibitors (PIs)
Integrase Inhibitors
Coreceptor Antagonists

Market segment by Application, split into
Hospitals
Clinics
Labs

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global HIV Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the HIV Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of HIV Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

For further information on this report, visit – https://www.wiseguyreports.com/reports/4080551-global-hiv-therapeutics-market-size-status-and-forecast-2019-2025

Table of Contents

1 Report Overview

2 Global Growth Trends

3 Market Share by Key Players

4 Breakdown Data by Type and Application

5 United States

6 Europe

7 China

8 Japan

9 Southeast Asia

10 India

11 Central & South America

12 International Players Profiles

13 Market Forecast 2019-2025

14 Analyst's Viewpoints/Conclusions

15 Appendix

Continuous..

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Shooting and Gun Accessories Market 2019 Global Opportunity Analysis And Industry Forecasts To 2024

Shooting and Gun Accessories -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024

PUNE, MAHARASHTRA, INDIA, May 31, 2019 /EINPresswire.com/ — Shooting and Gun Accessories Industry

Description

The report analyses the global Shooting and Gun Accessories market, the market size and growth, as well as the major market participants. 

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.

The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report. 

Key Companies 

Crosman  
Umarex  
Gamo  
Feinwerkbau  
Shanghai Air Gun  
Daisy  
Baikal  
Fujian Qingliu  
Anschutz  
Weihrauch  
Webley & Scott  
Daystate  
Hatsan  
Evanix  
BSA Guns 

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/4069596-shooting-and-gun-accessories-market-research-global-status

Key Regions 
Asia Pacific 
North America 
Europe 
South America 
Middle East & Africa 

Key Product Type 
Air Rifle  
Air Pistol 

Market by Application 
Hunting  
Competitive Sports 

Main Aspects covered in the Report Overview of the Shooting and Gun Accessories market including production, consumption, status & forecast and market growth 2015-2018 historical data and 2019-2025 market forecast Geographical analysis including major countries 
Overview the product type market including development 
Overview the end-user market including development

Table of Content 

1 Industrial Chain Overview 

2 Global Production & Consumption by Geography 

3 Major Manufacturers Introduction 

3.1 Manufacturers Overview 
3.2 Manufacturers List 
3.2.1 Crosman  Overview 
3.2.1.1 Product Specifications 
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 
3.2.1.3 Recent Developments 
3.2.1.4 Future Strategic Planning 
3.2.2 Umarex  Overview 
3.2.2.1 Product Specifications 
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 
3.2.2.3 Recent Developments 
3.2.2.4 Future Strategic Planning 
3.2.3 Gamo  Overview 
3.2.3.1 Product Specifications 
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 
3.2.3.3 Recent Developments 
3.2.3.4 Future Strategic Planning 
3.2.4 Feinwerkbau  Overview 
3.2.4.1 Product Specifications 
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 
3.2.4.3 Recent Developments 
3.2.4.4 Future Strategic Planning 
3.2.5 Shanghai Air Gun  Overview 
3.2.5.1 Product Specifications 
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 
3.2.5.3 Recent Developments 
3.2.5.4 Future Strategic Planning 
3.2.6 Daisy  Overview 
3.2.6.1 Product Specifications 
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 
3.2.6.3 Recent Developments 
3.2.6.4 Future Strategic Planning 
3.2.7 Baikal  Overview 
3.2.7.1 Product Specifications 
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 
3.2.7.3 Recent Developments 
3.2.7.4 Future Strategic Planning 
3.2.8 Fujian Qingliu  Overview 
3.2.8.1 Product Specifications 
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 
3.2.8.3 Recent Developments 
3.2.8.4 Future Strategic Planning 
3.2.9 Anschutz  Overview 
3.2.10 Weihrauch  Overview 
3.2.11 Webley & Scott  Overview 
3.2.12 Daystate  Overview 
3.2.13 Hatsan  Overview 
3.2.14 Evanix  Overview 
3.2.15 BSA Guns Overview 

Leave a Query @ https://www.wiseguyreports.com/enquiry/4069596-shooting-and-gun-accessories-market-research-global-status

4 Market Competition Pattern 

5 Product Type Segment 

6 End-Use Segment 

7 Market Forecast & Trend 

8 Price & Channel 

9 Market Drivers & Investment Environment 

10 Research Conclusion 

Continued…            

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Observando el extraño Eclipse Solar Total

Gran multitud observando el Eclipse solar total

Gran multitud observando el Eclipse solar total

Gafas de Eclipse solar seguras

Gafas de Eclipse solar seguras

Los hombres que buscan el Eclipse solar

Los hombres que buscan el Eclipse solar

On July 2, 2019, millions of people across Argentina and Chile will witness a total and partial solar eclipse.

No use gafas de sol, filtros Polaroid, vidrio ahumado, película a color expuesta, película de rayos X o filtros de densidad neutra fotográfica.”

— Deborah Byrd, Astronomy Essentials

BUENO AIRES, ARGENTINA, May 31, 2019 /EINPresswire.com/ — La totalidad será visible en las provincias de Buenos Aires, Córdoba, San Luis, San Juan, Santa Fe y La Rioja. En el norte de Argentina, los espectadores podrán ver el 75% de obstrucción del Sol, y aproximadamente el 50% será visible en las partes más al sur del condado.

Para experimentar un evento tan extraño de manera segura, todos en todo el país, tanto dentro como fuera de la ruta de la totalidad, deberán comprar gafas de eclipse solar especialmente diseñadas o visores portátiles. Los fabricantes de óptica especializada en todo el país lanzan filtros solares para ayudar a las personas a prepararse para esta oportunidad de su vida.

Con el eclipse total de sol en Argentina a solo un mes, todos deben comenzar a planificar para verlo ahora. Es importante planificar dónde estará el 2 de julio de 2019, dependiendo de si desea presenciar el eclipse total o parcial de sol. Por otra parte, la preparación de gafas de eclipse solar es otra parte de la tarea.

Sus anteojos de eclipse solar o sus visores deben contar con la certificación ISO para protegerse de la luz infrarroja y ultravioleta dañina del sol. Debido a que las gafas especiales para eclipses y los visores de mano son aproximadamente 1.000 veces más oscuros que las gafas de sol normales, ofrecen la forma más segura de ver el eclipse parcial.

Durante aproximadamente tres minutos, el 2 de julio de 2019, las personas en toda Argentina detendrán sus tareas y mirarán al cielo para presenciar el eclipse total de sol. Esta es una oportunidad para que las organizaciones participen en el evento y suministren las gafas y los visores. Las gafas de eclipse solar hechas a medida se pueden usar para promocionar una marca, utilizando el logotipo de la empresa y los esquemas de color.

A medida que se acerca la fecha del eclipse, el costo de las gafas de eclipse solar tiende a aumentar o incluso peor; los suministros se agotan por completo. Para evitar que esto arruine este evento espectacular para usted y su familia, asegúrese de obtener sus lentes solares antes de tiempo. En la semana anterior al eclipse, el precio de las gafas se duplicará o incluso aumentará hasta cuatro veces. Prepárese y no se quede afuera. Para evitar el aumento de precio, obtenga sus lentes de eclipse solar ahora.

Tommy Hintz
Educacion Eclipse
+54 9 11 5747-9694
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

2 de julio 2019 total solar eclipse Argentina gafas de Sudamérica


Source: EIN Presswire

Diabetes Insulin Delivery Pen Market: United States Industry Analysis and Opportunity Assessment, 2019 – 2025

New Study On 2019-2025 Diabetes Insulin Delivery Pen Market United States Key Player, Demand, Growth, Opportunities and Analysis Forecast

PUNE , MAHARASHTRA, INDIA, May 31, 2019 /EINPresswire.com/ — United States Diabetes Insulin Delivery Pen Industry

New Study On “2019-2025 Diabetes Insulin Delivery Pen Market United States Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

The United States insulin delivery pen market is anticipated to reach US$ 5 billion by 2026, witnessing an impressive double-digit growth rate in the forecast period 2019 – 2026.

“United States Diabetes Insulin Delivery Pen Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2026” presents an in-depth assessment of the United States insulin delivery pen market dynamics, opportunities, future road map, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook in the United States insulin delivery pen market. The report includes historical data from 2013 to 2018 and forecasts until 2026.

Try Free Sample Report @ https://www.wiseguyreports.com/sample-request/3839401-united-states-diabetes-insulin-delivery-pen-market-companies

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues for insulin delivery pen and its segment smart, reusable and disposable insulin pen and illustrative forecast to 2026. A comprehensive analysis has been done on the market share of insulin delivery pen users and market size. The report provides clear insight into current and future developments of the United States insulin delivery pen market.

The report also provides an all-round analysis of an overall number of patients with diabetes and insulin users in the United States. Additionally, the report includes an assessment of reimbursement pattern and offers a clear view of the regulatory landscape of the insulin delivery pens. The report also explores detailed description of growth drivers and inhibitors of the United States insulin delivery pen market.

The report concludes with the profiles of major players in the United States insulin delivery pen market. The key market players are evaluated on various parameters such as business overview, products offered and recent development.

Market Segment by Type, the Product can be Split into

Smart Insulin Delivery Pens 
• Reusable Insulin Delivery Pens 
• Disposable Insulin Delivery Pens

The Latest Industry Data Included in this Report:

United States Diabetes Population and Forecast (2013 – 2026) 
• United States Insulin Users and Forecast (2013 – 2026) 
• United States Insulin Delivery Pen Users and Forecast (2013 – 2026) 
• United States Insulin Delivery Pen Market and Forecast (2013 – 2026) 
• United States Insulin Delivery Pen Users and Y–o–Y Growth (%), 2013 – 2026 
• United States Insulin Delivery Pen Market Share and Y–o–Y Growth (%), 2013 – 2026 
• Reusable Insulin Delivery Pen Users and Forecast (2013 – 2026) 
• Reusable Insulin Delivery Pen Market and Forecast (2013 – 2026) 
• Disposable Insulin Delivery Pen Users and Forecast (2013 – 2026) 
• Disposable Insulin Delivery Pen Market and Forecast (2013 – 2026) 
• Smart Insulin Delivery Pen Users and Forecast (2013 – 2026) 
• Smart Insulin Delivery Pen Market and Forecast (2013 – 2026) 
• United States Insulin Delivery Pen Reimbursement Policies 
• United States Insulin Delivery Pen Regulation System 
• Market Definition for the Specified Topic Along with Identification of Key Drivers and Inhibitors for the Market 
• A Comprehensive List of Key Market Players Along with the Analysis of their Current Products Offered and Recent Development

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Novo Nordisk 
• Eli Lilly 
• Sanofi 
• Owen Mumford 
• Companion Medical 
• Diabnext 
• Digital Medics Ptd Ltd. 
• Emperra GmbH E-Health Technologies 
• Diamesco Co., Ltd.

For Detailed Reading Please visit WiseGuy Reports @  https://www.wiseguyreports.com/reports/3839401-united-states-diabetes-insulin-delivery-pen-market-companies

Some Major Points from Table of content:

1. Executive Summary
2. United States Diabetes Population & Forecast (2013 – 2026)
3. United States Insulin Users & Forecast (2013 – 2026)
4. United States Insulin Delivery Pen Users & Market Analysis (2013 – 2026)
5. United States Insulin Delivery Pen Users, Market Share& Y–o–Y Growth (%), 2013 – 2026
6. United States Insulin Delivery Pen Devices Users & Market Forecast (2013 – 2026)
7. Key Drivers and Inhibitors of the United States Insulin Delivery Pen Market
8. United States Insulin Delivery Pen Reimbursement Policies & Regulation System
9. Key Companies Analysis

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
8411985042
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Oncology/Cancer Blockbuster Drugs Market: Global Industry Analysis and Opportunity Assessment, 2019 – 2025

New Study On 2019-2025 Oncology/Cancer Blockbuster Drugs Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast

PUNE , MAHARASHTRA, INDIA, May 31, 2019 /EINPresswire.com/ — Global Oncology/Cancer Blockbuster Drugs Industry

New Study On “2019-2025 Oncology/Cancer Blockbuster Drugs Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

The global 27 cancer blockbuster drugs market size is set to surpass US$ 120 billion by 2025.

“Global Oncology/Cancer Blockbuster Drugs Market Research Report 2019 – 2025” presents an in-depth assessment of the global cancer blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for global cancer blockbuster drugs market. The report includes historical data from 2015 to 2018 and forecasts until 2025.

Try Free Sample Report @ https://www.wiseguyreports.com/sample-request/3904175-global-oncology-cancer-blockbuster-drugs-market-research-report-2019-2025

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the global cancer blockbuster drugs market. The report explores detailed analysis of top 27 drugs market assessment globally from 2015 to 2018 and forecasts to 2025.

Key trends in terms of collaboration, merger & acquisition, partnerships, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the global cancer blockbuster drugs market.

The report concludes with the profiles of major players in the global cancer blockbuster drugs market. The key market players are evaluated on various parameters such as business overview and recent development.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are: 

1. Roche 
2. Bristol-Myers Squibb 
3. Pfizer 
4. Eli Lilly and Company 
5. Merck 
6. Johnson & Johnson 
7. AstraZeneca 
8. Celgene 
9. Novartis 
10. Amgen 

For Detailed Reading Please visit WiseGuy Reports @  https://www.wiseguyreports.com/reports/3904175-global-oncology-cancer-blockbuster-drugs-market-research-report-2019-2025

Top 27 Cancer Blockbuster Drugs Covered Under This Report Are:

Imbruvica 
2. Revlimid 
3. Pomalyst/Imnovid 
4. Keytruda 
5. Herceptin 
6. Avastin 
7. MabThera/Rituxan 
8. Perjeta 
9. Opdivo 
10. Sprycel 
11. Ibrance 
12. Zytiga 
13. Tagrisso 
14. Darzalex 
15. Xtandi 
16. Jakafi/Jakavi 
17. Yervoy 
18. Alimta 
19. Gleevec/Glivec 
20. Velcade 
21. Tasigna 
22. Xgeva 
23. Afinitor/Votubia 
24. Neulasta 
25. Exjade Jadenu 
26. Sandostatin 
27. Faslodex 

The Latest Industry Data Included in this Report: 

Global Top 27 Cancer Blockbuster Drugs Market Size & Analysis (2015 – 2025) 
Global Top 27 Cancer Blockbuster Drugs Market Share & Y–o–Y Growth (%), 2015 – 2025 
Global Top 27 Cancer Blockbuster Drugs Market Assessment & Opportunity, (2015 – 2025) 
Major Deals (Mergers, Acquisitions, Key Agreements, Partnerships & Collaborations) 
Key Market Drivers and Inhibitors of the Global Cancer Blockbuster Drugs Market 
Major Companies Analysis 

The Report Answers the Following Questions about the Global Cancer Blockbuster Drugs Market: 

What is the size of the global top 27 cancer blockbuster drugs market during 2015 -2025? 
What will be the revenue generated by each drug during the forecast period? 
Which major drugs provides highest market share? 
How are the overall market and major drugs growing? 
What are the key drivers and inhibitors in the current market? 
What will be the impact of drivers and inhibitors in the future? 
How is the market predicted to develop in the future? 
Who are the key players in this market space?

Some Major Points from Table of content:

1. Executive Summary
2. Global Top 27 Cancer Blockbuster Drugs Market Size & Analysis (2015 – 2025)
3. Global Top 27 Cancer Blockbuster Drugs Market Share & Y–o–YGrowth (%), 2015 – 2025
4. Key Drivers and Inhibitors of the Global Cancer Blockbuster Drugs Market
5. Global Top 27 Cancer Blockbuster Drugs Market Assessment & Opportunity, (2015 – 2025)
6. Major Deals in Cancer Drugs Market
7. Key Companies Analysis

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
8411985042
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Global Influenza Vaccines Market 2019 Global Trends, Demand, Segmentation and Opportunities Forecast To 2025

New Study On “2019-2025 Influenza Vaccines Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

PUNE , MAHARASHTRA, INDIA, May 31, 2019 /EINPresswire.com/ — Global Influenza Vaccines Industry

New Study On “2019-2025 Influenza Vaccines Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

The global influenza vaccines market size is expected to surpass USD 6 billion by 2025.

“Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2025” presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global influenza vaccines market. The report includes historical data from 2013 to 2018 and forecasts until 2025.

Try Free Sample Report @ https://www.wiseguyreports.com/sample-request/3997659-influenza-vaccines-market-global-industry-analysis-share-size

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the global influenza vaccines market. The report also explores a detailed analysis of the number of persons being vaccinated with influenza vaccines globally from 2013 to 2018 and forecasts to 2025.

Additionally, the report includes assessment of clinical trials, promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. It also provides a deep and thorough evaluation of the distribution channel and technique of the influenza vaccination. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the global influenza vaccines market.

Further, prudent analysis has been done on the competitor’s part, where four major players grab a major share of the global influenza vaccine market by net sales. Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus (CSL Limited) and AstraZeneca are the key influencers with their vaccines in the global influenza vaccines market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, Altimmune, FluGen, Moderna, Vaccitech, VaxInnate and BioDiem are making novel technology-based influenza vaccine which is likely to affect the market share during the forecast period.

The report concludes with the profiles of major players in the global influenza vaccines market. The key market players are evaluated on various parameters such as company overview, influenza vaccines portfolios, sales value analysis and recent development in the global influenza vaccines market.

The major and emerging companies dominating this market for its vaccines, services and continuous product developments are:

Sanofi Pasteur 
• GlaxoSmithKline (GSK) 
• Seqirus (CSL Limited) 
• AstraZeneca 
• Mylan 
• Sinovac Biotech Ltd. 
• Gamma Vaccines Pty Ltd. 
• Hualan Biological Engineering Inc. 
• Shanghai Institute of Biological Products Co., Ltd. 
• Novavax 
• Daiichi–Sankyo 
• Mitsubishi Tanabe Pharma 
• BiondVax Pharmaceuticals Ltd 
• Altimmune 
• FluGen 
• Moderna 
• Vaccitech 
• VaxInnate 
• BioDiem

For Detailed Reading Please visit WiseGuy Reports @  https://www.wiseguyreports.com/reports/3997659-influenza-vaccines-market-global-industry-analysis-share-size

Twenty-One Major Markets (21MM) covered in the report are as follows:

United States 
• Canada 
• Germany 
• France 
• Italy 
• Spain 
• United Kingdom 
• Netherlands 
• Sweden 
• Denmark 
• Poland 
• Norway 
• Finland 
• Ireland 
• Belgium 
• Australia 
• New Zealand 
• Japan 
• Brazil 
• China 
• India

The Latest Industry Data Included in this Report:

Global Influenza Vaccines Market Size and Analysis (2013 – 2025) 
• Global Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025) 
• Global Influenza Vaccines Market Share Analysis and Forecast (2013 – 2025) 
• Global Number of Persons Vaccinated with Influenza Vaccines Share and Forecast (2013 – 2025) 
• Global Influenza Vaccines Market in Top 21 Countries and Forecast (2013 – 2025) 
• Rapid Diagnostic Testing for the Management of Influenza 
• Global Distribution Channel and Technique of Influenza Vaccination 
• Promising Influenza Vaccines in Clinical Development 
• Major Deals in the Global Influenza Vaccines Market 
• Influenza Vaccines Clinical Trial Insights by Phase, Company & Country 
• Market Definition for the Specified Topic Along with Identification of Key Drivers and Inhibitors for the Market 
• A Comprehensive List of Key Market Players Along with the Analysis of their Current Vaccines Portfolios, Sales Value Analysis, and Recent Development

The Report Answers the Following Questions about the Global Influenza Vaccines Market:

How has the global influenza vaccines market performed so far and how will it perform in the coming years? 
• What are the key markets in the global influenza vaccines industry? 
• How many numbers of persons being vaccinated with influenza vaccines globally during 2013 – 2025? 
• What are the key drivers and inhibitors in the current market? 
• What are the various influenza vaccines available globally? 
• How is the market predicted to develop in the future? 
• Who are the key players in this market space?

Some Major Points from Table of content:

1. Executive Summary
2. Global Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
3. Global Influenza Vaccines Market Size and Analysis (2013 – 2025)
4. Global Influenza Vaccines Market Share Analysis and Forecast (2013 – 2025)
5. Key Drivers and Inhibitors of the Global Influenza Vaccines Market
6. Global Influenza Vaccines Market in Top 21 Countries – Geographical Landscape (Volume and Value) (2013 – 2025)
7. Rapid Diagnostic Testing for the Management of Influenza
8. Global Distribution Channel and Technique of Influenza Vaccination
9. Promising Influenza Vaccines in Clinical Development
10. Major Deals in the Global Influenza Vaccines Market
11. Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
12. Key Companies Analysis

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
8411985042
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Global Rheumatology Therapeutics Market 2019 Global Trends, Demand, Segmentation and Opportunities Forecast To 2025

New Study On 2019-2025 Rheumatology Therapeutics Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast

PUNE , MAHARASHTRA, INDIA, May 31, 2019 /EINPresswire.com/ — Global Rheumatology Therapeutics Industry

New Study On “2019-2025 Rheumatology Therapeutics Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

The report covers the analysis and forecast of the rheumatology therapeutics market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Mn).

The study provides a detailed view of the rheumatology therapeutics market, by segmenting it based on by drug types, by disease types, by method of administration, by distribution channel, and regional demand. The rise in geriatric population propels the growth of the rheumatology therapeutics market. Growing awareness about the nature of rheumatology therapy is another prime factor driving the market demand. Additionally, swift acceptance of new drugs for treatment of different types of rheumatic diseases fuels the demand of this market. 

Try Free Sample Report @ https://www.wiseguyreports.com/sample-request/3289650-global-rheumatology-therapeutics-market-by-drug-types-disease

Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by drug types, by disease types, by method of administration, by distribution channel in all regions. These include different business strategies adopted by the leading players and their recent developments.

A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the Rheumatology therapeutics market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the rheumatology therapeutics market.

The report provides the size of the Rheumatology therapeutics market in 2017 and the forecast for the next eight years up to 2025. The size of the global rheumatology therapeutics market is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been considered in estimating the growth of the global market.

Market estimates for this study have been based on revenue being derived through regional pricing trends. The Rheumatology therapeutics market has been analyzed based on expected demand. Bottom-up approach is done to estimate the global revenue of the rheumatology therapeutics market, split into regions. Based on drug types, disease types, method of administration, and by distribution channel the individual revenues from all the regions is summed up to achieve the global revenue for rheumatology therapeutics. Companies were considered for the market share analysis, based on their innovation and application and revenue generation. In the absence of specific data related to the sales of rheumatology therapeutics several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence.

The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Sanofi A.G., Takeda Pharmaceutical, AbbVie Inc., Pfizer Inc., Regeneron, Amgen Inc., and few others. 
The global rheumatology therapeutics market has been segmented into: 
Global Rheumatology Therapeutics Market: By Drug Types 
• Disease Modifying Anti-Rheumatic Drugs 
• Corticosteroids 
• Non-Steroidal Anti-Inflammatory Drugs 
• Immunosuppressant Drugs 
• Biologics 
Global Rheumatology Therapeutics Market: By Disease Types 
• Rheumatoid Arthritis 
• Gout 
• Osteoarthritis 
• Juvenile Idiopathic Arthritis 
• Scleroderma 
• Sjogren’s Syndrome 
• Others 

For Detailed Reading Please visit WiseGuy Reports @  https://www.wiseguyreports.com/reports/3289650-global-rheumatology-therapeutics-market-by-drug-types-disease

Global Rheumatology Therapeutics Market: By Method of Administration 
• Topical 
• Oral 
• Parenteral 
Global Rheumatology Therapeutics Market: By Distribution Channel 
• Hospital 
• Online 
• Retail 
• Others 
Global Rheumatology Therapeutics Market: By Geography 
• North America 
o U.S. 
o Canada 
o Mexico 
• Europe 
o U.K. 
o France 
o Germany 
o Italy 
o Rest of Europe 
• Asia Pacific 
o India 
o China 
o Japan 
o Rest of Asia Pacific 
• Middle East and Africa 
o South Africa 
o Rest of Middle East and Africa 
• Latin America 
o Brazil 
o Rest of Latin America

Some Major Points from Table of content:

1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
5 GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY DRUG TYPES
6 GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY DISEASE TYPE
7 GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY METHOD OF ADMINISTRATION
8 GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL
9 GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY GEOGRAPHY
10 GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY COMPANY

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
8411985042
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire